In this episode, we’re joined by Dr. Marc Hoffmann from The University of Kansas Cancer Center, to explore chronic lymphocytic leukemia (CLL)—what it is, how it’s treated today, and where research is headed. Dr. Hoffmann shares insights on treatment goals, side effect management, and the importance of shared decision making. We also touch on emerging
Elevated glucose uptake-associated metabolic activity in visceral and subcutaneous adipose tissue with gout could contribute to chronic kidney disease (CKD) progression.
At Earth.com, our goal is to provide the internet with a homepage for anything and everything about our planet Earth and the environment.
By Heather Norman-BurgdoffUniversity of Kentucky Ticks are bad news in general, but the lone star tick brings an extra problem: it can leave behind a…
Phase 2 study shows eprenetapopt and azacitidine achieve 69% response rate in TP53-mutated MDS/AML, with 41% complete remission.
chadi nabhan MD, MBA, FACP’s Space · Where live audio conversations happen
In this episode of JACC This Week, Editor-in-Chief Dr. Harlan Krumholz introduces the journal’s new design and highlights key studies from the July 29, 2025…
chadi nabhan MD, MBA, FACP’s Space · Where live audio conversations happen
AbstractCardiovascular disease (CVD) and cancer are leading causes of death globally, particularly among the rapidly growing population of older adults (OAs). CVD is a leading…
Higher scores on a dietary index linked to gut microbiota health are associated with slower biological aging in US adults, according to a large cross-sectional…
A new study has found a link between rapid eye movement (REM) sleep and Alzheimer’s disease.
